Voyager Therapeutics, Inc. (VYGR) — Stock Score Summary

Voyager Therapeutics, Inc. (VYGR) has a MoatMap StockRank of 20/100 based on Quality (23/100), Value (42/100), and Momentum (40/100) factor scores. The current signal is STRONG SELL. Early-stage biotech company with high cash burn and binary clinical trial risks, failing our quality and margin of safety requirements.

Voyager Therapeutics, Inc. is a gene therapy company focused on developing treatments for severe neurological diseases, including Parkinson's disease and Huntington's disease. Its proprietary TRACER™ capsid discovery platform aims to enhance gene therapy delivery and efficacy, providing a potential advantage in a rapidly evolving field. Voyager is a clinical-stage biotechnology firm leveraging advanced gene therapy platforms for central nervous system disorders.

Key Financial Metrics

Price$3.60
Market Cap$236M
P/E (Forward)-2.30
Price/Book1.09
Return on Equity-52.3%
Return on Invested Capital-58.4%
Debt/Equity19.90
Gross Margin-243.5%
Operating Margin-1167.4%
Revenue Growth-59.9%
Free Cash Flow$-81M

Voyager Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Voyager Therapeutics, Inc.’s (VYGR) StockRank?
MoatMap’s StockRank for Voyager Therapeutics, Inc. (VYGR) is 20/100, with a Strong Sell signal. It is a composite of Quality (23), Value (42), and Momentum (40) factor ranks across MoatMap’s 19,000+ stock universe.
Does Voyager Therapeutics, Inc. have an economic moat?
Voyager Therapeutics, Inc. (VYGR) has a Quality factor score of 23/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Voyager Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Voyager Therapeutics, Inc. (VYGR) is Strong Sell, based on a StockRank of 20/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Voyager Therapeutics, Inc. in?
Voyager Therapeutics, Inc. (VYGR) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksVYGR deep dive reportAI ChampionsHow we score stocksSense-check another stock